2-Bromo-6-methoxynicotinic acid, 95%, 100mg

[3-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanol, 98%, 1g

15-Bromo-1-pentadecanol, 95.0%, 1g

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 1.00 µm, 1 Piece(s)

(5-oxo-2,3,5,6,7,8-hexahydrocyclopenta[d][1,3]thiazolo[3,2-a]pyrimidin-3-yl)acetic acid, 95.0%, 2.5g

(S)-3-(tert-Butoxycarbonylamino)piperidine>98.0%(GC)1g

N-Cbz-6-Amino-hexan-1-ol, 95.0%, 100g

1-[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]methanamine, 95.0%, 5g

2-(tert-Butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid, 98.0%, 10g

(2S)-3-[tert-Butoxycarbonyl(isopropyl)amino]-2-(4-chlorophenyl)propanoic acid, 95%, 5g

3-Bromo-5-fluorophenol>98.0%(GC)5g

6-Bromo-1,2,3,4-tetrahydroquinoline hydrochloride, 97%, 5g

2-Bromo-4-phenylthiazole, 97.0%, 100g